Literature DB >> 23675563

Aging- and activation-induced platelet microparticles suppress apoptosis in monocytic cells and differentially signal to proinflammatory mediator release.

Elena M Vasina1, Sandra Cauwenberghs, Mareike Staudt, Marion Ah Feijge, Christian Weber, Rory R Koenen, Johan Wm Heemskerk.   

Abstract

BACKGROUND: Platelet microparticles (PM) are the most abundant cell-derived microparticles in the blood, and accumulate in thrombo-inflammatory diseases. Platelets produce PM upon aging via an apoptosis-like process and by activation with strong agonists. We previously showed that long-term treatment of monocytic cells with apoptosis-induced PM (PMap) promotes their differentiation into resident macrophages. Here we investigated shorter term effects of various types of PM on monocyte signalling and function. METHODS AND
RESULTS: Flow cytometry and scanning electron microscopy revealed that PM formed upon platelet aging (PMap) or ultra-sonication (PMsonic) expressed activated αIIbβ3 integrins and tended to assemble into aggregates. In contrast, PM formed upon platelet activation with thrombin (PMthr) or Ca(2+) ionophore (PMiono) had mostly non-activated αIIbβ3 and little aggregate formation, but had increased CD63 expression. PM from activated and sonicated platelets expressed phosphatidylserine at their surface, while only the latter were enriched in the receptors CD40L and CX3CR1. All PM types expressed P-selectin, interacted with monocytic cells via this receptor, and were internalised into these cells. The various PM types promoted actin cytoskeletal rearrangements and hydrogen peroxide production by monocytic cells. Markedly, both aging- and activation-induced PM types stimulated the phosphoinositide 3-kinase/Akt pathway, suppressing apoptosis induced by several agonists, in a P-selectin-dependent manner. On the other hand, the PM types differentially influenced monocyte signalling in eliciting Ca(2+) fluxes (particularly PMap) and in releasing secondary mediators (complement factor C5a with PMap, and pro-inflammatory tumour necrosis factor-α with PMthr).
CONCLUSIONS: In spite of their common anti-apoptotic potential via Akt activation, aging- and activation-induced PM cause different Ca(2+) signalling events and mediator release in monocytic cells. By implication, aging and activated platelets may modulate monocyte function in different way by the shedding of different PM types.

Entities:  

Keywords:  Aging; apoptosis; microparticles; monocytes; platelet activation; tumour necrosis factor

Year:  2013        PMID: 23675563      PMCID: PMC3649808     

Source DB:  PubMed          Journal:  Am J Blood Res        ISSN: 2160-1992


  46 in total

1.  Platelet-derived microparticles in patients with arteriosclerosis obliterans: enhancement of high shear-induced microparticle generation by cytokines.

Authors:  S Nomura; A Imamura; M Okuno; Y Kamiyama; Y Fujimura; Y Ikeda; S Fukuhara
Journal:  Thromb Res       Date:  2000-05-15       Impact factor: 3.944

Review 2.  Flow cytometry of apoptotic cell death.

Authors:  I Vermes; C Haanen; C Reutelingsperger
Journal:  J Immunol Methods       Date:  2000-09-21       Impact factor: 2.303

3.  Shedding of procoagulant microparticles from unstimulated platelets by integrin-mediated destabilization of actin cytoskeleton.

Authors:  Sandra Cauwenberghs; Marion A H Feijge; Alan G S Harper; Stewart O Sage; Joyce Curvers; Johan W M Heemskerk
Journal:  FEBS Lett       Date:  2006-09-12       Impact factor: 4.124

4.  Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737.

Authors:  Victoria Del Gaizo Moore; Jennifer R Brown; Michael Certo; Tara M Love; Carl D Novina; Anthony Letai
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

5.  Anucleate platelets generate progeny.

Authors:  Hansjörg Schwertz; Sarah Köster; Walter H A Kahr; Noemi Michetti; Bjoern F Kraemer; David A Weitz; Robert C Blaylock; Larry W Kraiss; Andreas Greinacher; Guy A Zimmerman; Andrew S Weyrich
Journal:  Blood       Date:  2010-01-19       Impact factor: 22.113

Review 6.  Microparticles in hemostasis and thrombosis.

Authors:  A Phillip Owens; Nigel Mackman
Journal:  Circ Res       Date:  2011-05-13       Impact factor: 17.367

Review 7.  Function and role of microparticles in various clinical settings.

Authors:  Shosaku Nomura; Yukio Ozaki; Yasuo Ikeda
Journal:  Thromb Res       Date:  2008-07-29       Impact factor: 3.944

Review 8.  Clearance of apoptotic cells: implications in health and disease.

Authors:  Michael R Elliott; Kodi S Ravichandran
Journal:  J Cell Biol       Date:  2010-06-28       Impact factor: 10.539

9.  Microparticles from apoptotic platelets promote resident macrophage differentiation.

Authors:  E M Vasina; S Cauwenberghs; M A H Feijge; J W M Heemskerk; C Weber; R R Koenen
Journal:  Cell Death Dis       Date:  2011-09-29       Impact factor: 8.469

10.  Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes.

Authors:  Gabriella Passacquale; Padman Vamadevan; Luis Pereira; Colleen Hamid; Valerie Corrigall; Albert Ferro
Journal:  PLoS One       Date:  2011-10-12       Impact factor: 3.240

View more
  20 in total

1.  Time courses and value of circulating microparticles in patients with operable stage non-small cell lung cancer undergoing surgical intervention.

Authors:  Chia-Cheng Tseng; Chin-Chou Wang; Chang-Chun Hsiao; Hung-I Lu; Steve Leu; Huang-Chih Chang; Kuo-Tung Huang; Wen-Feng Fang; Yu-Mu Chen; Shih-Feng Liu; Cheng-Ta Yang; Meng-Chih Lin; Hon-Kan Yip
Journal:  Tumour Biol       Date:  2016-04-08

Review 2.  Platelet-rich plasma: combinational treatment modalities for musculoskeletal conditions.

Authors:  Isabel Andia; Michele Abate
Journal:  Front Med       Date:  2017-10-18       Impact factor: 4.592

3.  2-Arachidonoylglycerol enhances platelet formation from human megakaryoblasts.

Authors:  Valeria Gasperi; Luciana Avigliano; Daniela Evangelista; Sergio Oddi; Valerio Chiurchiù; Mirko Lanuti; Mauro Maccarrone; Maria Valeria Catani
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

4.  Antithrombotic Therapy: Prevention and Treatment of Atherosclerosis and Atherothrombosis.

Authors:  R H Olie; P E J van der Meijden; H M H Spronk; H Ten Cate
Journal:  Handb Exp Pharmacol       Date:  2022

5.  Co-administration of platelet-rich plasma and small intestinal submucosa is more beneficial than their individual use in promoting acute skin wound healing.

Authors:  Xiaoxuan Lei; Liuhanghang Cheng; Yu Yang; Mengru Pang; Yunqing Dong; Xuanru Zhu; Caihong Chen; Zexin Yao; Gang Wu; Biao Cheng; Tymour Forouzanfar
Journal:  Burns Trauma       Date:  2021-11-30

Review 6.  Neutrophil derived microvesicles: emerging role of a key mediator to the immune response.

Authors:  Bobby L Johnson; Josh W Kuethe; Charles C Caldwell
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2014       Impact factor: 2.895

7.  Acid sphingomyelinase is activated in sickle cell erythrocytes and contributes to inflammatory microparticle generation in SCD.

Authors:  Anthony O Awojoodu; Philip M Keegan; Alicia R Lane; Yuying Zhang; Kevin R Lynch; Manu O Platt; Edward A Botchwey
Journal:  Blood       Date:  2014-07-29       Impact factor: 22.113

8.  Process and procedural adjustments to improve CD34+ collection efficiency of hematopoietic progenitor cell collections in sickle cell disease.

Authors:  Scott T Avecilla; Farid Boulad; Karina Yazdanbakhsh; Michel Sadelain; Patricia A Shi
Journal:  Transfusion       Date:  2021-06-23       Impact factor: 3.337

Review 9.  Extracellular Vesicles: Versatile Nanomediators, Potential Biomarkers and Therapeutic Agents in Atherosclerosis and COVID-19-Related Thrombosis.

Authors:  Adriana Georgescu; Maya Simionescu
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

10.  Differential regulation of the apoptotic machinery during megakaryocyte differentiation and platelet production by inhibitor of apoptosis protein Livin.

Authors:  I Abd-Elrahman; V Deutsch; M Pick; S Kay; T Neuman; R Perlman; D Ben-Yehuda
Journal:  Cell Death Dis       Date:  2013-11-28       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.